USANA Health Sciences USNA EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from USANA Health Sciences’s reported figures.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's EBITDA?
- USANA Health Sciences (USNA) reported EBITDA of $22.15M in Q1 2026.
- How has USANA Health Sciences's EBITDA changed year-over-year?
- USANA Health Sciences's EBITDA decreased by 7.7% year-over-year, from $24.01M to $22.15M.
- What is the long-term trend for USANA Health Sciences's EBITDA?
- Over 3 years (2022 to 2025), USANA Health Sciences's EBITDA has grown at a -16.7% compound annual growth rate (CAGR), from $121.01M to $69.99M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.